// App-Quantinova.ai

3055 : Ponatinib and Cardiovascular Complications

Researchers

Presenter

  • Alvin H. Schmaier

Principal Investigators

  • Alona A. Merkulova

  • Steven Mitchell

  • Evi X Stavrou

Medical Centers

  • Division of Hematology-Oncology, Case Western Reserve University, Cleveland, OH

  • Department of Medicine, Division of Hematology-Oncology, Case Western Reserve University/University Hospital Case Medical Center, Cleveland, OH

  • Division of Hematology-Oncology, Case Western Reserve University/Louis Stokes Veterans Administration Hospital, Cleveland, OH

  • Department of Pathology, School of Medicine, Case Western Reserve University, Cleveland, OH

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Venous thrombosis

Biomarkers

  • Peroxisome proliferator activated receptor

Drug/Treatment

  • Thiazolidinedione

  • Pioglitazone

  • Actoplus Met XR extended-release tablet

  • Ponatinib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved